Can depressed cancer patients with a borderline thiamine concentration develop deficiency within a short time period?
- 23 January 2023
- journal article
- case report
- Published by Cambridge University Press (CUP) in Palliative and Supportive Care
- Vol. 21 (4) , 768-771
Abstract
Background Despite increasing reports of thiamine deficiency (TD) among cancer patients, there remain some patients with borderline thiamine concentrations (BTC). However, it is unclear whether such patients subsequently develop TD. Methods Here, we report cases of cancer patients progressing to TD within a short time period after presentation with BTC (24–28 ng/ml). Results Case 1 A 49-year-old female with lung cancer. During treatment for depression, the patient showed a decreased appetite, and a blood sample revealed BTC (25 ng/ml). Fourteen days later, she reported a continued loss of appetite, and despite the absence of the 3 classical signs of Wernicke encephalopathy (WE), additional testing showed a thiamine level of 23 ng/ml, leading to a diagnosis of TD. Case 2 A 65-year-old female developed depression during chemotherapy for angiosarcoma. Her blood sample revealed BTC (25 ng/ml). Seven days later, despite the absence of the classical signs of WE, a further testing revealed a thiamine level of 20 ng/ml. Case 3 A 41-year-old female developed depression during chemotherapy for ovarian cancer. No loss of appetite was observed, but a blood sample revealed BTC (25 ng/ml). Seven days later, despite the absence of the classical signs of WE or decreased appetite, further testing revealed a thiamine level of 19 ng/ml. Significance of results Depressed cancer patients with BTC may develop TD within a short time frame. To prevent TD, health-care professionals should maintain an awareness of its potential and the need for regular testing of thiamine level or prophylactic replacement therapy.Keywords
This publication has 14 references indexed in Scilit:
- Thiamine deficiency in a patient with recurrent renal cell carcinoma who developed weight loss with normal appetite and loss of energy soon after nivolumab treatmentPalliative and Supportive Care, 2019
- Wernicke encephalopathy in a lung cancer patient during treatment with nivolumabPalliative and Supportive Care, 2018
- High rate of thiamine deficiency among inpatients with cancer referred for psychiatric consultation: results of a single site prevalence studyPsycho-Oncology, 2016
- Advances in clinical determinants and neurological manifestations of B vitamin deficiency in adultsNutrition Reviews, 2016
- Wernicke-Korsakoff-Syndrome: Under-Recognized and Under-TreatedPsychosomatics, 2012
- Wernicke's encephalopathy: new clinical settings and recent advances in diagnosis and managementThe Lancet Neurology, 2007
- Thiamine deficiency in patients admitted to a palliative care unitPalliative Medicine, 1994
- Clinical signs in the Wernicke-Korsakoff complex: a retrospective analysis of 131 cases diagnosed at necropsy.Journal of Neurology, Neurosurgery & Psychiatry, 1986
- Thiamin status of patients treated with drug combinations containing 5-fluorouracil1980
- Effects of 5-Fluorouracil on the Thiamin Status of Adult Female RatsChemotherapy, 1979